- Home
- OCS vs DHC Comparison
OCS vs DHC Comparison
Compare OCS & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- DHC
- Stock Information
- Founded
- OCS 2003
- DHC 1998
- Country
- OCS Switzerland
- DHC United States
- Employees
- OCS N/A
- DHC N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- DHC Real Estate Investment Trusts
- Sector
- OCS Health Care
- DHC Real Estate
- Exchange
- OCS Nasdaq
- DHC Nasdaq
- Market Cap
- OCS 717.3M
- DHC 629.7M
- IPO Year
- OCS N/A
- DHC N/A
- Fundamental
- Price
- OCS $17.31
- DHC $2.44
- Analyst Decision
- OCS Strong Buy
- DHC Hold
- Analyst Count
- OCS 5
- DHC 3
- Target Price
- OCS $29.20
- DHC $4.50
- AVG Volume (30 Days)
- OCS 39.4K
- DHC 856.3K
- Earning Date
- OCS 11-07-2024
- DHC 11-04-2024
- Dividend Yield
- OCS N/A
- DHC 1.66%
- EPS Growth
- OCS N/A
- DHC N/A
- EPS
- OCS N/A
- DHC N/A
- Revenue
- OCS $1,027,571.00
- DHC $1,477,343,000.00
- Revenue This Year
- OCS $6.87
- DHC N/A
- Revenue Next Year
- OCS $884.16
- DHC $5.26
- P/E Ratio
- OCS N/A
- DHC N/A
- Revenue Growth
- OCS N/A
- DHC 6.62
- 52 Week Low
- OCS $10.11
- DHC $2.19
- 52 Week High
- OCS $18.00
- DHC $4.24
- Technical
- Relative Strength Index (RSI)
- OCS 68.45
- DHC 39.32
- Support Level
- OCS $15.45
- DHC $2.37
- Resistance Level
- OCS $17.92
- DHC $2.50
- Average True Range (ATR)
- OCS 0.50
- DHC 0.10
- MACD
- OCS 0.17
- DHC 0.02
- Stochastic Oscillator
- OCS 81.42
- DHC 40.24
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.